APP2021: Professor David Hunter on how pharmacists can facilitate more positive OA management outcomes


Osteoarthritis (OA) is a leading cause of disability that affects more than 3 million Australians. At APP 2021, Professor David Hunter, Florance and Cope Chair of Rheumatology, Professor of Medicine, the University of Sydney spoke to Miranda Deakin about the opportunities for pharmacists to facilitate more positive OA management outcomes for patients.     This video is proudly supported by GSK Consumer Healthcare

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Is the revolution coming?
Next List of pharmacy case locations grows